Polycystic ovary syndrome: clinical implication in perimenopause - Wikidata - awgldk - TriplyDB

Polycystic ovary syndrome: clinical implication in perimenopause

Polycystic ovary syndrome: clinical implication in perimenopause

http://www.wikidata.org/entity/Q26795581

about

Polycystic ovary syndrome: clinical implication in perimenopause

http://www.wikidata.org/entity/Q26795581

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Polycystic ovary syndrome: clinical implication in perimenopause

@ast

Polycystic ovary syndrome: clinical implication in perimenopause

@en

Polycystic ovary syndrome: clinical implication in perimenopause

@nl

type

label

Polycystic ovary syndrome: clinical implication in perimenopause

@ast

Polycystic ovary syndrome: clinical implication in perimenopause

@en

Polycystic ovary syndrome: clinical implication in perimenopause

@nl

prefLabel

Polycystic ovary syndrome: clinical implication in perimenopause

@ast

Polycystic ovary syndrome: clinical implication in perimenopause

@en

Polycystic ovary syndrome: clinical implication in perimenopause

@nl

P1433

Q26795581-BFDC8C3C-EE42-4DE9-8872-0A51A8BAD207

P1476

Q26795581-1EA92292-8BEF-4CF9-9DDE-D97156A11FB6

P2093

Q26795581-2EEA1BAF-D115-4612-9FF2-043D9AF68EEA

Q26795581-478D0447-31A6-4B79-918E-4DDBFBFF9747

Q26795581-4C5F8E11-5B8A-4B91-A272-2880FF9987B2

Q26795581-67926763-2057-45C8-BCDE-9AACCD4F1C1A

Q26795581-8C23790C-A796-408E-98B2-CAAFCB68D490

P2860

Q26795581-0317B8E4-7A91-4C43-B6C6-3FDC7A0A05A9

Q26795581-07D550A3-48F5-4E3D-A170-2874695DDF69

Q26795581-1F98613E-EDB1-467E-B66F-E4CBAAC57D04

Q26795581-3FAF2FD2-70A7-492B-95EF-EB99B2ABFF6B

Q26795581-4B4AD882-7136-4CB4-B239-B0952FD9C0B0

Q26795581-4E7657CA-8BA7-454B-BF96-BF7125364A6D

Q26795581-53CC8BA4-5425-4A63-AC69-459F376FF5B1

Q26795581-647BA682-E5DF-47A7-A489-1BF340F551F6

Q26795581-6991600A-012F-459E-BFDE-C1B496B666B0

Q26795581-716FCD01-B7ED-49D5-A38F-B14192B95844

P304

Q26795581-EC8D2A3E-6BEF-4768-ACCB-8C6AFB585521

P31

Q26795581-C8523AC1-93BE-4C48-ABF3-5A80B33EB12A

P356

Q26795581-8BCFB025-3BEC-4A59-95EE-4FFF5C4091AC

P407

Q26795581-8CB78263-2752-4B42-B573-72A7F1036845

P433

Q26795581-2214BE80-AAA9-4BE0-A0E0-26461B72AB75

P478

Q26795581-FC6E0475-385D-4B26-B704-FB2E70AD8F54

P50

Q26795581-A12684C1-6E5E-44DB-8AA6-4EF0D2D5E0B7

P577

Q26795581-E7B7F978-0329-43C0-BD7D-73011E8F89F8

P5875

Q26795581-5731E315-DDEC-4FFF-9537-D826E3E8529F

P698

Q26795581-C7DA6C31-BCBA-4459-8EFF-E9287DC2D148

P921

Q26795581-5A0502ED-7D59-4249-883E-A1165E7CD7A3

Q26795581-8533E6B7-F828-48C4-8255-2757A8A92078

P932

Q26795581-9D25CFE7-AD5E-44BF-B82C-53C209CC96FC

P356

P1433

Przegląd Menopauzalny / [red. nacz. Tomasz Pertyński]

P1476

Polycystic ovary syndrome: clinical implication in perimenopause

@en

P2093

Beata Matyjaszek-Matuszek

http://www.w3.org/2001/XMLSchema#string

Ewa Woźniakowska

http://www.w3.org/2001/XMLSchema#string

Jerzy S Tarach

http://www.w3.org/2001/XMLSchema#string

Monika Lenart-Lipińska

http://www.w3.org/2001/XMLSchema#string

Tomasz Paszkowski

http://www.w3.org/2001/XMLSchema#string

P2860

Polycystic ovary syndrome and its developmental origins.

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis.

Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.

Insulin and cancer.

PCOS: a diagnostic challenge.

Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute spons

Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women.

Polycystic ovarian syndrome.

Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease

P304

348-351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/PM.2014.47988

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276304090

http://www.w3.org/2001/XMLSchema#string

P698

26327878

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome

obstetrics and gynaecology

P932

4352911

http://www.w3.org/2001/XMLSchema#string